Skip to main navigation menu Skip to main content Skip to site footer
Brazilian Journal of Clinical Medicine and Review

Health Review

Vol. 1 No. 1 (2023): January/March - 2023

HIV Vulnerability Associated with Dementia in Non-Elderly Individuals: An Integrative Review

DOI
https://doi.org/10.52600/2965-0968.bjcmr.2023.1.1.46-49
Submitted
February 1, 2023
Published
2023-02-01

Abstract

Acquired Immunodeficiency Syndrome (AIDS) was discovered in the 1980s as a sexually transmitted infectious disease and considered a major public health problem. HIV presents very accentuated neurotropism, leading to the appearance of neurological syndromes, mainly in more chronic phases of the infectious process. The most frequent alterations are vacuolar myelopathy and a picture of cerebral atrophy, progressive dementia, and peripheral neuropathies, all related to the action of HIV and the immune system itself in the central and peripheral nervous tissue. HIV-associated dementia contributes to the morbidity of the infection and is a risk factor for mortality. Prior to the use of antiretroviral therapy, over 15% of individuals with AIDS had dementia and over 15% of minor motor cognitive impairment. Advanced infection is a risk factor for the development of dementia both in the pre- and post-pharmacological treatment era. Considering the aspects, the present study aimed to carry out an integrative literature review on the pathophysiological aspects of the relationship between dementia and HIV carriers.

References

  1. Casseb J, Caterino-de-Araujo A, Hong MA, Salomão S, Gallo D, Hendry RM, Duarte AJ. Prevalence of HTLV-I and HTLV-II infections among HIV-1-infected asymptomatic individuals in São Paulo, Brazil. Rev Inst Med Trop São Paulo. 1997;39(4):213-5.
  2. Montelli Terezinha CB, Soares Angela MVC, Parise-Fortes MR, Rezkallah-Iwasso MT, Padula Niura MR, Peraçoli MTS. Al-terations of cell-mediated immune response in children with febrile seizures. Arq. Neuro-Psiquiatr.1997;55(2):193-198.
  3. Garlipp CR, Rossi CL, Bottini PV. Cerebrospinal fluid profiles in acquired immunodeficiency syndrome with and without neurocryptococcosis. Rev. Inst. Med. Trop. S. Paulo. 1997;39(6):323-326.
  4. Pereira CP. Alterações cognitivas na infecção pelo HIV e AIDS. Rev. Assoc. Med. Bras. 2010;56(2):242-247.
  5. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology. 1993;43:2245-52.
  6. Sacktor NC, Bacellar H, Hoover DR, Nance-Sproson TE, Selnes OA, Miller EN, et al. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol. 1996;2:404-10.
  7. Sackor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol. 2002;2(Suppl):115-21.
  8. Whitemore R, Knafl K. The integrative review: update methodology. J Adv Nurs. 2005;52(5):546-53.
  9. Cardoso ALF, de Melo LGM, Santos FC, Lorenzini EA, Meirelles Betina Hörner Schlindwein MBH. Perda auditiva em pessoas com HIV/AIDS e fatores relacionados: uma revisão integrativa. Braz. j. otorhinolaryngol; 79(2): 248-255; 2013.
  10. Schaurich RD, Stein BD, Freitas HMB, Zamberlan C, Gelhen MH, Colomé JS. Conhecimentos produzidos acerca do crack: uma incursão nas dissertações e teses brasileiras. Ciênc. saúde coletiva. 2012;17(5):1247-1258.
  11. Rotta I, Monteiro AS. Genotypical diversity of HIV clades and central nervous system impairment. Arq. Neuro-Psiquiatr. 2011;69(6):964-972.
  12. Sánchez-Sosa JJ, Cázares RO, Piña LJA, Mariana DT. Un modelo psicológico en los comportamientos de adhesión terapéutica en personas con VIH. Salud Ment. 2009;32(5):389-397.
  13. Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl. 1):S19-S25.'

Most read articles by the same author(s)

<< < 1 2